K. Heinonen

HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality

D. M. Richards, Matthias Schröder, C. Merz, 2019, Journal of Immunotherapy for Cancer.

A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity

D. M. Richards, C. Merz, C. Gieffers, 2018, Front. Oncol..

Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture.

R. Bartenschlager, Wolfgang Fischl, C. Steuer, 2011, Bioorganic & medicinal chemistry.

The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell–mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells

D. M. Richards, C. Merz, C. Gieffers, 2018, Journal of immunotherapy.

Abstracts from the 4th ImmunoTherapy of Cancer Conference

R. Rees, F. Regnier, A. Trautmann, 2017, Journal of Immunotherapy for Cancer.

The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy

T. Illidge, Matthias Schröder, C. Merz, 2023, Frontiers in Immunology.

Optimization of Assay Conditions fo r Dengue Virus Protease: Effect of Various Polyols and Nonionic Detergents

C. Steuer, C. Klein, K. Heinonen, 2009, Journal of biomolecular screening.